CILATIL, TADALAFIL ALPHAPHARM (Alphapharm Pty Ltd)
Product name
CILATIL, TADALAFIL ALPHAPHARM
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
135 (255 working days)
Active ingredients
tadalafil
Registration type
New generic medicine
Indication
CILATIL,TADALAFIL ALPHAPHARM (tablet) is indicated for the treatment of:
- erectile dysfunction (ED) in adult males
- moderate to severe lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH) in adult males